Skip to main content
Have a personal or library account? Click to login
Lipoprotein(a) Levels in Thyroid Disorders Cover

Lipoprotein(a) Levels in Thyroid Disorders

Acta Marisiensis - Seria Medica
Volume 59 (2013): Issue 2 (April 2013)
By:  and    
Open Access
|Aug 2013
References

References

  1. 1. Berg K. A new serum type system in man: the Lipoprotein(a) system. Acta Pathol Microbiol Scand. 1963;59:369-382.
    Open DOISearch in Google Scholar
  2. 2. Watts GF, Keamey EM, Taub NA, Slavin BM. Lipoprotein(a) as an independent risk factor for myocardial infarction in patients with common hypercholesterolaemia. Jf Clin Patho. 1993;46:267-270.
    Open DOISearch in Google Scholar
  3. 3. Zhu X, Cheng SY. New insights into regulation of lipid metabolism by thyroid hormone. Current Opinion in Endocrinology, Diabetes and Obesity. 2010;17(5):408-413.
    Open DOISearch in Google Scholar
  4. 4. Fruchart JC, Nierman MC, Stroes ES, Kastelein JJ, Duriez P. New risk factors for atherosclerosis and patient risk assessment. Circulation. 2004;109III:15-19.
    Open DOISearch in Google Scholar
  5. 5. Discepolo W, Wun T, Berglund L. Lipoprotein(a) and thrombocytes: potential mechanisms underlying cardiovascular risk. Pathophysiol Haemost Thromb. 2006;35:314-21.
    Open DOISearch in Google Scholar
  6. 6. Koschinsky ML. Novel insights into Lp(a) physiology and pathogenicity: more questions than answers? Cardiovasc Hematol Disord Drug Targets. 2006;6:267-78.
    Search in Google Scholar
  7. 7. Anuurad E, Boffa MB, Koschinsky ML, Berglund L. Lipoprotein(a): a unique risk factor for cardiovascular disease. Clin Lab Med. 2006;26:751-72.
    Open DOISearch in Google Scholar
  8. 8. Zorio E, Falco C, Arnau MA, et al. Lipoprotein(a) in young individuals as a marker of the presence of ischemic heart disease and the severity of coronary lesions. Haematologica. 2006;91:562-5.
    Search in Google Scholar
  9. 9. Santi A, Duarte M, Moresco RN, et al. Association between thyroid hormones, lipids and oxidative stress biomarkers in overt hypothyroidism. Clinical Chemistry and Laboratory Medicine. 2010;48(11):1635-1639.
    Open DOISearch in Google Scholar
  10. 10. Roos A, Bakker SJ, Links TP, Gans RO, Wolffenbuttel BH. Thyroid function is associated with components of the metabolic syndrome in euthyroid subjects. J Clin Endocrinol Metab. 2007;92:491-6.
    Open DOISearch in Google Scholar
  11. 11. Peppa M, Betsi G, Dimitriadis G. Lipid Abnormalities and Cardiometabolic Risk in Patients with Overt and Subclinical Thyroid Disease. J Lipids. 2011; 2011: 575840. Published online 2011 July 18. doi: 10.1155/2011/575840.
    Search in Google Scholar
  12. 12. Asvold BO, Vatten LJ, Nilsen TI, Bjoro T. The association between TSH within the reference range and serum lipid concentrations in a populationbased study. The HUNT Study. Eur J Endocrinol. 2007;156:181-6.
    Search in Google Scholar
  13. 13. Enkhmaa B, Anuurad E, Zhang W, Tran T, Berglund L. Lipoprotein(a): genotype-phenotype relationship and impact on atherogenic risk. Metab Syndr Relat Disord. 2011;9(6):411-8.
    Open DOISearch in Google Scholar
  14. 14. Bruckert E, Thomas D. Les hypercholesterolemies. John Libbey Eurotext, London, 1997, 28-53.
    Search in Google Scholar
  15. 15. Takagi H. Atorvastatin decreases lipoprotein(a): a meta-analysis of randomized trials. Int J Cardiol. 2012;154(2):183-6.
    Open DOISearch in Google Scholar
  16. 16. Dumitrescu L, Glenn K, Brown-Gentry K et al. Variation in LPA is associated with Lp(a) levels in three populations from the Third National Health and Nutrition Examination Survey. 2011 PLoS ONE 6 (1): e16604.
    Open DOISearch in Google Scholar
  17. 17. Nordestgaard BG, Chapman MJ, Ray K, Borén J, Andreotti F, Watts GF et al. Lipoprotein(a) as a cardiovascular risk factor: current status. Eur. Heart J. 2010;31(23):2844-53.
    Open DOISearch in Google Scholar
  18. 18. Dubé JB, Boffa MB, Hegele RA, Koschinsky ML. Lipoprotein(a): more interesting than ever after 50 years. Curr Opin Lipidol. 2012;23(2):133-40.
    Open DOISearch in Google Scholar
  19. 19. George RM, Torelli J. Beyond cholesterol: 7 life-saving heart disease tests that your doctor may not give you. New York: St. Martin's Griffin. 2005. p.91.
    Search in Google Scholar
  20. 20. De Bruin TW, van Barlingen H, van Linde-Sibenius TM, et al. Lipoprotein(a) and Apolipoprotein B plasma concentrations in hypothyroid, euthyroid and hyperthyroid subjects. J Clin Endocrinol Metab. 1993;76:121-126.
    Search in Google Scholar
  21. 21. Rizos CV, Elisaf MS, Liberopoulos EN. Effects of Thyroid Dysfunction on Lipid Profile. Open Cardiovasc Med J. 2011;5:76-84.
    Open DOISearch in Google Scholar
  22. 22. Boda J, Paragh G, Szabo J, et al. Lipoprotein(a) studies in thyroid diseases. Orv Hetil. 1997;138:2307.
    Search in Google Scholar
  23. 23. Lotz H, Salabe GB. Lipoprotein(a) increase associated with thyroid autoimmunity. Eur J Endocrinol. 1997;136(1):87-91.
    Open DOISearch in Google Scholar
  24. 24. Bairaktari ET, Tselepis AD, Millionis HJ, Elisaf MS. Lipoprotein(a) levels, apoLipoprotein(a) phenotypes and thyroid autoimmunity. Eur J Endocrinol. 1999;140:474-6.
    Open DOISearch in Google Scholar
  25. 25. Tagami T, Tamanaha T, Shimazu S, et al. Lipid profiles in the untreated patients with Hashimoto thyroiditis and the effects of thyroxine treatment on subclinical hypothyroidism with Hashimoto thyroiditis. Endocrine Journal. 2010;57(3):253-258.
    Open DOISearch in Google Scholar
  26. 26. Toruner F, Altinova AE, Karakoc A, et al. Risk factors for cardiovascular disease in patients with subclinical hypothyroidism. Adv Ther. 2008; 25:430-7.
    Open DOISearch in Google Scholar
  27. 27. Dullaart RPF, van Doormaal JJ, Hoogenberg K, Sluiter WJ. Triiodothyronine rapidly lowers plasma Lipoprotein(a) in hypothyroid subjects. Netherlands Journal of Medicine. 1995;46(4):179-184.
    Open DOISearch in Google Scholar
  28. 28. Lee WY, Suh JY, Rhee EJ, et al. Plasma CRP, apolipoprotein A-1, apolipoprotein B and Lp(a) levels according to thyroid function status. Arch Med Res. 2004;35:540-5.
    Open DOISearch in Google Scholar
  29. 29. Lippi G, Targher G, Montagnana M, Salvagno GL, Guidi GC. Relationship between Lipoprotein(a) and thyroid function status in the general population. Arch Med Res. 2007;38:905-6.
    Open DOISearch in Google Scholar
  30. 30. Riche DM, East HE, Priest HM. Practical management of dyslipidemia with elevated Lipoprotein(a). J Am Pharm Assoc. 2008;48(6):803-7.
    Open DOISearch in Google Scholar
  31. 31. Neves C, Alves M, Medina JL, Delgado JL. Review Thyroid diseases, dyslipidemia and cardiovascular pathology. Rev Port Cardiol. 2008; 27(10):1211-36.
    Search in Google Scholar
  32. 32. Teixeira P, Reuters VS, Ferreira MM, et al. Lipid profile in different degrees of hypothyroidism and effects of levothyroxine replacement in mild thyroid failure. Translational Research. 2008;151(4):224-231.
    Open DOISearch in Google Scholar
DOI: https://doi.org/10.2478/amma-2013-0018 | Journal eISSN: 2668-7763 (formerly 2247-6113) | Journal ISSN: 2668-7755
Journal RSS Feed
Language: English
Page range: 81 - 84
Published on: Aug 13, 2013
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
hypothyroidism,
hyperthyroidism,
Lipoprotein(a)
Related subjects:
Medicine,
Clinical medicine,
Clinical medicine, other

© 2013 Cristina Corina Pop-Radu, Mirela Gliga, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons License.

Volume 59 (2013): Issue 2 (April 2013)
Previous article
Next article